Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis

Abstract: Lenalidomide is associated with increased risk of thromboembolism (VTE) in patients with multiple myeloma. This risk has not previously been defined in B-cell non-Hodgkin lymphoma (NHL), for which lenalidomide is also an active agent. We conducted a systematic literature search in Ovid MED...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Blood Advances
المؤلفون الرئيسيون: Samuel Yamshon, Paul J. Christos, Michelle Demetres, Hoda Hammad, John P. Leonard, Jia Ruan
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Elsevier 2018-06-01
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2473952920309678

مواد مشابهة